Citigroup Inc Akoya Biosciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 19,303 shares of AKYA stock, worth $57,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,303

Previous 5,797 232.98%

Holding current value

$57,136

Previous $13,000 300.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.96 - $2.94 $26,471 - $39,707	13,506 Added 232.98%	19,303 $52,000
Q2 2024 Aug 12, 2024	BUY	$1.94 - $4.56 $3,748 - $8,809	1,932 Added 49.99%	5,797 $13,000
Q1 2024 May 10, 2024	BUY	$4.33 - $6.06 $1,935 - $2,708	447 Added 13.08%	3,865 $18,000
Q4 2023 Feb 09, 2024	BUY	$3.13 - $5.13 $10,638 - $17,436	3,399 Added 17889.47%	3,418 $16,000
Q3 2023 Nov 09, 2023	SELL	$4.24 - $7.44 $22,883 - $40,153	-5,397 Reduced 99.65%	19 $0
Q2 2023 Aug 10, 2023	BUY	$5.28 - $8.35 $28,596 - $45,223	5,416 New	5,416 $40,000
Q4 2022 Feb 09, 2023	SELL	$8.6 - $14.1 $1,126 - $1,847	-131 Reduced 51.98%	121 $1,000
Q3 2022 Nov 10, 2022	SELL	$10.63 - $15.76 $8,195 - $12,150	-771 Reduced 75.37%	252 $3,000
Q2 2022 Aug 10, 2022	BUY	$8.38 - $12.85 $4,407 - $6,759	526 Added 105.84%	1,023 $13,000
Q1 2022 May 12, 2022	SELL	$9.84 - $14.97 $30,956 - $47,095	-3,146 Reduced 86.36%	497 $5,000
Q4 2021 Feb 10, 2022	BUY	$11.37 - $15.31 $31,210 - $42,025	2,745 Added 305.68%	3,643 $56,000
Q3 2021 Nov 10, 2021	BUY	$13.04 - $21.0 $11,709 - $18,858	898 New	898 $13,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

12M

Call Options Held

24.1K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $112M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account